Literature DB >> 11834266

Herpes simplex encephalitis: the role of surgical decompression.

Hwa-Jeng Yan1.   

Abstract

BACKGROUND: The role of acyclovir for the treatment of herpes simplex encephalitis has been well documented, but the role of surgical decompression for herpes simplex encephalitis has only rarely been mentioned. The authors report two cases of herpes simplex encephalitis that involved surgical decompression. CASE DESCRIPTION: In the first case, a therapeutic regimen of acyclovir was begun on the 11(th) day of the clinical course, and surgical decompression was performed because of impending uncal herniation on the 13(th) day. In the second case, a therapeutic regimen of acyclovir was begun on the third day of the disease's clinical course, and surgical decompression was performed because of impending uncal herniation on the 11(th) day. Both patients had good neurological outcomes and were seizure-free 12 months after their surgical procedures.
CONCLUSION: We conclude that, for patients with herpes simplex encephalitis, it is important for the clinician to detect deterioration of consciousness because of the mass effect caused by the disease-associated inflammatory process as early as is possible. Surgical decompression is indicated for impending uncal herniation or intolerable increased intracranial pressure. Such surgery can contribute to an improved outcome for patients with herpes simplex encephalitis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11834266     DOI: 10.1016/s0090-3019(01)00688-7

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  10 in total

1.  Decompressive craniectomy in cerebral toxoplasmosis.

Authors:  D Agrawal; N Hussain
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-11       Impact factor: 3.267

2.  Predictors of outcome in acute encephalitis.

Authors:  Kiran T Thakur; Melissa Motta; Anthony O Asemota; Hannah L Kirsch; David R Benavides; Eric B Schneider; Justin C McArthur; Romergryko G Geocadin; Arun Venkatesan
Journal:  Neurology       Date:  2013-07-26       Impact factor: 9.910

Review 3.  Anterior Temporal Lobectomy for Refractory Status Epilepticus in Herpes Simplex Encephalitis.

Authors:  Sarah K B Bick; Saef Izzy; Daniel B Rubin; Sahar F Zafar; Eric S Rosenthal; Emad N Eskandar
Journal:  Neurocrit Care       Date:  2016-12       Impact factor: 3.210

Review 4.  Does size matter? Decompressive surgery under review.

Authors:  Arthur R Kurzbuch
Journal:  Neurosurg Rev       Date:  2015-04-12       Impact factor: 3.042

5.  A Case Report of Herpes Simplex-1 Viral Encephalitis Complicated by Hemorrhagic Conversion.

Authors:  Jane Ehret; Ali Al Safi; Chika Akabusi; Oluwafemi Ajibola; David Kung
Journal:  Cureus       Date:  2022-04-18

6.  A case of herpes simplex encephalitis revealed by decompressive craniectomy.

Authors:  N Bayram; D Yilmaz Ciftdogan; B Karapinar; E Ozgiray; M Polat; E Cagliyan; F Vardar
Journal:  Eur J Pediatr       Date:  2007-10-03       Impact factor: 3.183

7.  Herpes Simplex Encephalitis Complicated by Cerebral Hemorrhage during Acyclovir Therapy.

Authors:  Yukinori Harada; Yuuta Hara
Journal:  Intern Med       Date:  2017-01-15       Impact factor: 1.271

8.  Long-term outcome of severe herpes simplex encephalitis: a population-based observational study.

Authors:  Youenn Jouan; Leslie Grammatico-Guillon; Fabien Espitalier; Xavier Cazals; Patrick François; Antoine Guillon
Journal:  Crit Care       Date:  2015-09-21       Impact factor: 9.097

9.  Intracranial Hemorrhage Complicating Herpes Simplex Encephalitis on Antiviral Therapy: A Case Report and Review of the Literature.

Authors:  Ghada ElShimy; Christina Mariyam Joy; Fred Berlin; Waleed Lashin
Journal:  Case Rep Infect Dis       Date:  2017-09-19

Review 10.  Decompressive craniectomy for herpes simplex encephalitis complicated by frank intracerebral hemorrhage: a case report and review of the literature.

Authors:  Yoon Hwan Byun; Eun Jin Ha; Sang-Bae Ko; Kyung Hyun Kim
Journal:  BMC Neurol       Date:  2018-10-23       Impact factor: 2.474

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.